Zefopenam Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Meropenem

Indications/Uses

Pneumonia including nosocomial pneumonia; UTI; gynecological, skin & skin-structure infections; meningitis, septicaemia. Empiric treatment for presumed infections w/ febrile neutropenia as a single agent or in combination w/ antiviral or antifungal agents. Polymicrobic infections as a single agent or in combination w/ other antibiotics.

Click to view Zefopenam detailed prescribing information

Dosage/Direction for Use

Adult Pneumonia, UTI, gynaecological, skin & skin-structure infections 500 mg IV 8 hrly. Nosocomial pneumonia, peritonitis, presumed infections in febrile neutropenia, septicaemia 1 g IV 8 hrly Meningitis 2 g 8 hrly. Renal impairment CrCl 26-50 mL/min 1 unit dose 12 hrly, CrCl 10-25 mL/min ½ unit dose 12 hrly, CrCl <10 mL/min ½ unit dose 24 hrly. Childn>3 mth-12 yr 10-20 mg/kg 8 hrly, >50 kg Adult dose. Childn Meningitis 40 mg/kg 8 hrly.

Click to view Zefopenam detailed prescribing information

Overdosage

View Zefopenam overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity to meropenem or anaphylactic reactions to β-lactams.

Click to view Zefopenam detailed prescribing information

Special Precautions

Monitor of transaminase & bilirubin levels in patients w/ hepatic disease. Overgrowth of non-susceptible organisms may occur. Not recommended for use in methicillin-resistant staphylococci infections. Pseudomembranous colitis. History of GI complaints. Caution in co-administration w/ potentially nephrotoxic drugs. Not recommended in infant <3 mth. Pregnancy & lactation.

Click to view Zefopenam detailed prescribing information

Use In Pregnancy & Lactation

Click to view Zefopenam detailed prescribing information

Adverse Reactions

Inflammation, thrombophlebitis, pain at the site of inj. Rash, pruritus, urticaria; rare severe skin reactions eg, erythema multiforme, Stevens-Johnson syndrome & toxic epidermal necrolysis. Abdominal pain, nausea, vomiting, diarrhoea, pseudomembranous colitis. Reversible thrombocythaemia, eosinophilia, thrombocytopenia, leucopenia & neutropenia; +ve direct or indirect Coombs test may develop; reduced partial thromboplastin time. Increased serum conc of bilirubin, transaminases, alkaline phosphatase & lactic dehydrogenase. Headache, paraesthesiae. Oral & vaginal candidiasis.

Click to view Zefopenam detailed prescribing information

Drug Interactions

Increased plasma conc w/ probenecid. May reduce serum valproic acid levels.

Click to view Zefopenam detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Zefopenam detailed prescribing information

Storage

View Zefopenam storage conditions for details to ensure optimal shelf-life.

Description

View Zefopenam description for details of the chemical structure and excipients (inactive components).

Action

View Zefopenam mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Beta-Lactams

ATC Classification

J01DH02 - meropenem ; Belongs to the class of carbapenems. Used in the systemic treatment of infections.

Regulatory Classification

POM

Presentation/Packing

Form

Zefopenam powd for inj 1 g

Packing/Price

30 mL x 1's

Zefopenam

meropenem

Manufacturer:

Zifam Pinnacle

Distributor:

Pinnacle House